ARTICLE | Company News
NRM, XZL Alzheimer's vaccine deal
October 4, 2001 7:00 AM UTC
Neurochem (TSE:NRM) and Select Therapeutics (XZL) will collaborate to develop a beta-amyloid vaccine to prevent Alzheimer's disease (AD). XZL will use its Verovax technology to deliver NRM's AD antige...